// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

A Prospective Randomized Clinical Trial on the Timing of Rectal Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis: A Preliminary Report

Pernilla -Souza - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Peptic ulcer

Indomethacin

Protease Inhibitors for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials

Yuhong Yuan - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Pancreatitis

Ulinastatin

Clinical Utility of Biliary Metal Stent Use Across a Broad Range of Indications - Interim Results of a Large Prospective Multi-Centre Canadian Registry

Andre Roy - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Intraductal papillary mucinous neoplasm

N/A

Does Self-Assessment Accuracy of Clinical Colonoscopies Differ Among Endoscopists of Varying Levels of Expertise? A Prospective, Cross-Sectional Study

Samir C. Grover - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Catheter-Based Acoustic Interrogation Device for Real-Time Monitoring of the Dynamics of the Lower Esophageal Sphincter: A Pilot Canine Study

Bangmao Wang - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroesophageal reflux disease

N/A

Immunogenic Gluten Is Modulated by Small Intestinal Bacterial Hydrolysis

Heather J. Galipeau - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dysbiosis

Elaszym

Establishing new OCT parameters: Is race-specific phenotypingnecessary?

B. Chauhan - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Does IOL choice impact on Driving Performance?

G. Beiko - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Candidate Retinal Biomarkers in CNS NeurodegenerativeDisease

C. Hudson - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Are we there yet?

L.A. Levin - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Two Sisters with Congenital Blindness caused by OsteoporosispseudogliomaSyndrome due to new Mutations in the LPR5 Gene

Robitaille J M - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis pseudoglioma syndrome

N/A

Light-Induced Retinopathy in neonatal rats: A new retinaldegeneration slow model

Polosa A - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

N/A

MMP-9 null mice display elevated IOP due to reduced aqueoushumor drainage from the trabecular meshwork

Siwakoti A - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Modulation of the contrast response function of V1 neurons bythe pulvinar

Lai J - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Background ophthalmological changes following subretinalinjection in the brown norway rat

Li C - European Association for Vision and Eye Research (EVER) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Isoflurane

Hypovitaminosis D in pregnancy: can the Mediterranean paradox be explained? A systematic review

Stavroula A Paschou - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

Ergocalciferol

Use of infliximab (Remicade ) for IBD within a patient support program: Positive perception of i.v. infusions from patien-s perspective

Dajnowiec Dorota - European Crohn’s and Colitis Organisation (ECCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Infliximab

Assessment of community structure and predictive functional profiling of the mucosa-associated microbiome implicates alterations in benzoate metabolism in-de nov- IBD after pouch-surgery and in treatment-naive pediatric IBD

J. Connors - European Crohn’s and Colitis Organisation (ECCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

NaBen

Looking Behind the Smokescreen: Cannabis,Cognition and Multiple Sclerosis.

Anthony Feinstein - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Multiple Sclerosis

N/A

RecoveryFrom Postconcussion Syndrome.

P. DUFORT - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Postconcussion syndrome

N/A

Copyright © 2026. QuantiNova All rights reserved